SwedenBIO’s Post

This year the LSX Nordic Congress is bringing more opportunities than ever before to connect, collaborate, and form lasting relationships with life science innovators and leaders across Northern Europe, as well as international investors! This year's agenda will be looking at the growth and internationalisation of the Nordic region and its transformation into a global hub of innovation. 90+ speakers have already been confirmed including global heads at AstraZeneca, Novo Nordisk, and Genmab and international investors from Forbion, Sunstone Life Science Ventures, and Novo Venture. You can also get involved in: • Networking Drinks: Providing you with the opportunity to informally network and build relationships with key figures in the Northern European life science community • Qualified partnering: Pre-arrange private meetings with your preferred participants ahead of the event with our user-friendly conference partnering platform. Search, filter, and auto-schedule to build your personal itinerary with ease • Showcases: These sessions are designed to highlight Nordic innovation and investment opportunities from across the region. If you're fundraising there's no better place to be, you'll have access to 150+ specialist life science investors Secure the best rate, and book before 28 June to save up to €650. Find out more - https://lnkd.in/eCkHc4Rq #LSXNordic #Biotech #Medtech #healthtech #pharma #investors

𝗪𝗿𝗮𝗽𝗽𝗶𝗻𝗴 𝗨𝗽 𝗕𝗜𝗢-𝗘𝘂𝗿𝗼𝗽𝗲 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟰 𝗶𝗻 𝗕𝗮𝗿𝗰𝗲𝗹𝗼𝗻𝗮 💼    As we bid farewell to BIO-Europe Spring 2024, let's take a moment to reflect on the lively atmosphere and collaborative spirit that filled the event's halls.    ✨ Facts & Figures ✨    🤝 ~120,000 meeting requests  🤝 ~20,000 meetings  🏢 1,947 companies represented  👥 3,452 delegates attended  💌 MONIPOL prepared ~280 meeting requests and had 25 meetings    These numbers speak volumes about the energy and collaboration present at the event. We were fortunate to connect with many companies interested in exploring our services: throughout the event, we made it a priority to prepare thoroughly and understand our potential clients' needs. This emphasis on research and client-centricity beforehand ensured that meetings were not only productive but also truly beneficial for everyone involved 🤝    𝐇𝐚𝐯𝐞 𝐲𝐨𝐮 𝐦𝐢𝐬𝐬𝐞𝐝 𝐭𝐡𝐞 𝐜𝐡𝐚𝐧𝐜𝐞 𝐭𝐨 𝐜𝐨𝐧𝐧𝐞𝐜𝐭 𝐰𝐢𝐭𝐡 𝐮𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐞𝐯𝐞𝐧𝐭? Don't worry! Contact us for follow-ups and learn more about how we can support your trials. Let's continue the conversation and explore exciting opportunities at the Virtual Partnering Event, held on 26-27 March 📅     A big thank you to everyone who made BIO-Europe Spring 2024 such a success. We are looking forward to connecting further and supporting innovative biotech pioneers.    Another big thanks to EBD Group for providing a platform to connect the global BioPharma community. We are pleased to have played a part in fostering this vibrant atmosphere.      #BIOEuropeSpring #Biotech #CRO #clinicaltrials #clinicaldevelopment 

So Many Conferences — So Little Time: Which Conference to Visit? I often get asked by companies and industry stakeholders which conferences they should visit or which are worth attending in the first half of the year. I have been in the circle for 25 years now and there is no straight answer. The standard response is, it depends on what you are looking for. If you are looking for general partnering, there are a number of big conferences like the BIO International Convention and "#bioeuropespring", where you can meet people from all over the world. However, there are also some (smaller) regional-focused conferences like the "Swiss Biotech Day #swissbiotechday", which has grown to over 1,800 participants, or the "Asia Bio Partnering Forum #ASIABIO" and BIO KOREA. There are also therapeutic or technology-focused conferences like Advanced Therapies in London, Festival of Biologics in San Diego, or The World Vaccine Congress in DC. If you are fundraising, there are options like the BIO CEO & Investor Conference in NY for more mature (public) companies, "RESI Conferences Life Science Nation (LSN) (Atlanta and Barcelona) for earlier stage (private) companies, as well as LSX World Congress in London or The Annual European Life Sciences CEO Forum #Sachs_ELSF" in Zurich. Additionally, different investment banks host conferences, of which "JPM by JPMorgan Chase & Co." in San Francisco is where the industry meets. For very intimate interactions with other Biotech CEOs, I can recommend the "Biotech CEO Summit CEO Summit by Demy-Colton" in Barcelona and La Jolla. You can find all these conferences, along with their dates and links here https://lnkd.in/dawnkF6p

Join us for the next 𝐒𝐏𝐀𝐑𝐊 𝐄𝐮𝐫𝐨𝐩𝐞 𝐖𝐞𝐛𝐢𝐧𝐚𝐫❗ 🔹 𝐃𝐫 Marcin Szumowski, with over 20 years of management experience in innovative R&D projects in the biotech and medical diagnostics fields, will be diving into his experience in funding early stage companies (medtech and drug development) and the long term effects of early funding decisions. Learn i.a.: 🔍 where to look for the funding of your start-up apart from friends, family and fools, ✅ when to choose grant funding and when is the right time for an external investor, 🎯what to look for when investor-hunting, apart from money.   🔸Title of the webinar: “𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐧𝐠 𝐨𝐟 𝐞𝐚𝐫𝐥𝐲 𝐬𝐭𝐚𝐠𝐞 𝐬𝐭𝐚𝐫𝐭-𝐮𝐩𝐬” 🗓 𝟎𝟐.𝟏𝟎.𝟐𝟎𝟐𝟒 at 4 pm (online) Registration to the webinar is required in advance➡️ https://lnkd.in/dDDi2DpN More information➡️ https://lnkd.in/dtd_G93q

The launch is nearing! Keep tabs on the upcoming funding call in ODIN - our patent-free collaboration platform for drug discovery and better diagnostics. We have lined up a few events where you can get the information you need and perhaps meet future project partners? 1.     The ODIN kick-off conference On 27 May, we’ve planned a day full of information and networking in Copenhagen. We believe that the conference is the perfect starting point for new collaborations across industry and academia. Participation is of course free of charge and anyone interested can join us by signing up here: https://lnkd.in/d5pYfdeS   2.     ODIN information meetings In case you’re not able to make it to the kick-off conference, we’ve planned a series of information meetings at the Danish partner universities. At these 1-hour events, I’ll give an in-depth introduction to ODIN and let you in on the details of how to apply for project funding for open research collaborations. You can find the time and place, which suits you best on ODIN’s website: https://lnkd.in/dbZaRzVV   3. Also, please follow ODIN’s LinkedIn page to learn more about what an ODIN project looks like. In the following weeks, ODIN’s LinkedIn page will give you examples of previous ODIN projects to let you in on the many different ways of approaching open collaborations and what the grant holders learned. Find ODIN’s LinkedIn page here: https://lnkd.in/dsXQFS-S   If you have questions regarding ODIN, you are always welcome to reach out.

🌟 What's New in Drug Discovery? Let's Dive In! 🌟 Hello, fellow drug discovery aficionados! The world of drug discovery is always buzzing with new challenges and innovations. Let’s talk about what’s currently shaping our industry. 🔬 Key Needs in Drug Discovery: - Cutting-Edge Technology: What new tools are revolutionizing your lab work? - Collaboration: How do we build stronger partnerships for faster breakthroughs? - Regulatory Hurdles: What’s the best way to navigate the ever-changing landscape? 💡 Emerging Trends: - AI and Big Data: How are these tools enhancing our research capabilities? - Personalized Medicine: What strides are we making in tailoring treatments? - Sustainability: How are we making our processes greener? 💬 Your Thoughts? I’d love to hear from you! What’s the biggest challenge you’re facing in drug discovery today? What innovations are you most excited about? Drop a comment or send me a message—let’s get a conversation going! 🚀 Let's Connect! By the way, if you're as passionate about these topics as I am, we’ve got an incredible opportunity to dive deeper. The 17th DDSS Summit in Munich on October 23-24 will be a fantastic place to meet, learn, and share ideas. Feel free to message me for more details! 🔗 https://lnkd.in/dSmySJWC #DrugDiscovery #Pharma #HealthcareInnovation #AIinHealthcare #PrecisionMedicine #Sustainability #Networking #DDSSSummit

Join this incredible line up of panelists for a discussion around DEIB and its evolving philosophies. Register below! #diversity #DEIB #lifesciences #biospace

🌟 Exciting Reflections from COG Nordics 2024! 🌟 Last week, I had the pleasure of chairing a C-Suite panel at the COG Nordics conference in #Copenhagen, diving deep into the intricacies of funding for Nordic clinical-stage #biotechs. Joined by industry #leaders from MyCural Therapeutics, Alder Therapeutics, Amplio Pharma, and Node Pharma, we explored essential strategies to navigate the complex landscape of investment funding for clinical trials. Key Takeaways: - Early-Stage Funding: The critical role of securing initial resources can significantly impact the success and progress of clinical trials. - Expert Guidance: Leveraging expert advice is vital for bridging the communication gap between scientists and investors. - Networking: The importance of building robust connections within industry events to foster potential investment and collaboration opportunities. - Track Record: Establishing a credible and successful history to attract and reassure investors. Missed out on this insightful discussion? Don’t worry! Join us for our next meeting in Amsterdam this November for more enriching experiences. 🌍 Read Here: https://lnkd.in/efwYKWtT 📈 #Biotech #ClinicalTrials #InvestmentFunding #NordicBiotech #COGNordics2024 #HealthcareInnovation #ProfessionalNetworking

When will the IPO market reopen and funding flow again? This is the key question the BioCentury Inc.-The BayHelix Group East-West Summit after initial friendly chatter about the ongoing Taylor Swift concerts held nearby in Singapore which clearly sees no lack of spending commitments!   In the ever-evolving landscape of #biotech which is reliant on financing of long gestation drug development, start-ups and investors both locally and internationally gathered in Singapore to navigate these turbulent times. We're glad to support the event with our CEO and Executive Director Wai Chiew CHIK being part of the Organising Committee, to foster collaborative dialogues and actively supporting national initiatives to fortify Singapore's blossoming #startupecosystem.    Wai Chiew also participated in a session titled "Capital Markets Showcase: The Buyside View," joining a distinguished panel of experts including Curtis S. Chin (Milken Institute), George Lin (Hua Medicine), Jolene Ooi (EDBI Pte Ltd), Matthew Sheroff (The Janssen Pharmaceutical Companies of Johnson & Johnson), and Yue (Shelby) Zhang (Vertex Growth), with moderation by Steve Wang (Davis Polk & Wardwell LLP). Together, they delved into current market dynamics, treatment modalities, therapeutic areas of interest, market sentiment, access to capital, and the indispensable role of private-public partnerships in bolstering biotech endeavors.   We are grateful that the event was well attended, joined by esteemed attendees including public agencies, investors, ecosystem builders, and biotechs including A*STAR - Agency for Science, Technology and Research, ClavystBio, Pappas Capital, August Global Partners, Guardant Health, Polaris Partners, Leaps by Bayer, SGInnovate, Enterprise Singapore, GenFleet Therapeutics, Hummingbird Bioscience, Lerna Biopharma, Mirxes, JLABS, McKinsey & Company, Boehringer Ingelheim, Insilico Medicine, Experimental Drug Development Centre (EDDC), Accelerator Life Science Partners, Paratus Sciences etc.   #EastWestBiopharmaSummit